Selective targeting of lysyl oxidase-like 2 (LOXL2) suppresses hepatic fibrosis progression and accelerates its reversal
2017 · Gut · 292 citations
https://doi.org/10.1136/gutjnl-2016-312473
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
37
Papers
2.0K
Citations
15
h-index
16
i10-index
Deanna Sverdlov is an academic researcher from Tufts Medical Center. The author has contributed to research in topics: Liver Disease Diagnosis and Treatment & Liver physiology and pathology & Birth, Development, and Health. The author has an h-index of 15, co-authored 32 publications.
https://doi.org/10.1136/gutjnl-2016-312473
https://doi.org/10.1097/aog.0000000000005120
Click to start Chat